Topic: Diabetes

Sanofi announces positive results for diabetes drug

PARIS (Reuters) - French drugmaker Sanofi said a late-stage study of its lixisenatide drug in combination with Lantus insulin showed a significant improvement in blood sugar levels and a beneficial effect on body weight in type 2 diabetes patients.Lixisenatide, which will be ...

Moderate drinking tied to lower diabetes risk

Following more than 80,000 women over 26 years, researchers found that those who ate a diet high in refined carbohydrates, such as white bread, potatoes and sugary drinks, had a 30 percent lower risk of developing diabetes than women with similar eating ...

Traffic pollution may be linked to diabetes risk

Lindsey KonkelNEW YORK (Reuters Health) - People who live in areas with high levels of traffic-related air pollution may face a slightly increased risk of developing diabetes, Danish researchers conclude in a new study.They found that people living in urban areas with ...
Winnie Madikizela-Mandela, the ex-wife of Nelson Mandela, has been hospitalised in Johannesburg to treat her diabetes, the second time she has been admitted in three months, their daughter said on Friday."Mrs Winnie Madikizela-Mandela is being treated at Milpark Hospital for an existing ...

Asia's cell phone healthcare seen at $7 billion by 2017

HONG KONG (Reuters) - Mobile technologies will be increasingly deployed to enable people in Asia to monitor and manage their health, with the market expected to hit $7 billion by 2017, an industry official said.In parts of Europe and the United States, ...

Asia's mobile tech-driven healthcare market seen at $7 billion

HONG KONG (Reuters) - Mobile technologies will be increasingly deployed to enable people in Asia to monitor and manage their health, with the market expected to hit $7 billion by 2017, an industry official said.In parts of Europe and the United States, ...

Diabetes forecast to hit one in 10 adults by 2030

(Reuters) - One in 10 adults will have diabetes by 2030, posing a huge challenge to healthcare systems around the world, according to a report on Monday.The number of people living with the disease is expected to soar to 552 million by ...

Eli Lilly faces tough times with patent losses

HONOLULU (Reuters) - Eli Lilly and Co has hit a tough spot with the pharmaceutical company's top treatment now facing competition from cheaper generic brands and the looming loss of patent protection on other drugs."It may be one of our most challenging ...
India is facing a twin epidemic of diabetes and high blood pressure, doctors have warned, after the results of a countrywide study suggested that one in five people had both conditions.The two-year study of nearly 16,000 adults in eight states found that ...
A drug known as sulodexide has failed to show any benefit toward halting kidney failure in people with diabetes and an international trial has been stopped early, a US medical journal said Thursday.The drug, once seen as a potentially promising treatment to ...
Previous